Back to Results
First PageMeta Content
Drug discovery / Orphan drug / Non-24-hour sleep-wake disorder / National Organization for Rare Disorders / Rare disease / Health / Pharmaceuticals policy / Medicine


National Organization for Rare Disorders Remarks before the FDA Peripheral and Central Nervous System Drugs Advisory Committee Silver Spring, Maryland November 14, 2013 Good afternoon. My name is Diane Edquist Dorman, Vi
Add to Reading List

Document Date: 2013-11-14 16:15:36


Open Document

File Size: 180,16 KB

Share Result on Facebook

Company

Vanda Pharmaceuticals / /

Country

United States / /

IndustryTerm

biopharmaceutical / /

MedicalCondition

rare diseases / rare disorders / Rare disease / hour sleep-wake disorder / /

MedicalTreatment

alternative therapy / /

Organization

FDA / Peripheral & Central Nervous System Drugs Advisory Committee / Advisory Committee / National Organization for Rare Disorders Comments / National Organization for Rare Disorders Remarks / National Organization for Rare Disorders / /

Person

Diane Edquist Dorman / /

Position

Vice President for Public Policy / /

SocialTag